IPO - BiomX Inc.

Form Type: S-1

Filing Date: 2025-04-11

Corporate Action: Ipo

Type: New

Accession Number: 000121390025031169

Filing Summary: BiomX Inc. has filed a Registration Statement on Form S-1 with the SEC to register shares of common stock, including the resale of shares by selling securityholders. The offering includes up to 2,305,869 shares issuable upon exercise of pre-funded warrants, up to 5,939,383 shares issuable upon exercise of common warrants, and up to 6,955,528 shares issuable upon exercise of new warrants. The issuer will not receive proceeds from the selling securityholders' offering but will receive exercise prices upon any warrant exercises. The filing indicates that the securities will be traded on the NYSE American under the symbol 'PHGE'. Investment in these securities involves significant risk, and investors are advised to read the detailed risk factors associated with the company's operations and products, which are described in the accompanying prospectus. The prospectus outlines the nature of the company’s business in developing phage-based therapies for chronic diseases, its strategic offerings, and the anticipated use of proceeds from warrant exercises.

Document Link: View Document